Literature DB >> 15010558

Cervical disease and cancer in HIV positive women. Recommendations for screening and diagnosis.

Isabelle Heard1.   

Abstract

Cancer and cervical disease occur more frequently in HIV infected women than in HIV negative. HIV infection is associated with an increased prevalence and severity of Human Papilloma Virus (HPV) associated cervical intraepithelial lesions. Advanced HIV disease is the strongest independent risk factor for cancer associated HPV infection. Up to now, there have been limited and controversial data on the effect of High Active Antiretroviral Therapy (HAART) on the natural history of cervical lesions. The major risk factors associated with cervical cancer detection are similar in HIV positive and negative women and include lack of screening and prolonged duration of symptoms. HIV positive women should have a complete gynaecological examination, including a Pap test, which should be performed twice in the first year after the diagnosis of HIV infection. Referral for colposcopy and biopsy should be recommended in case of abnormal cytology.

Entities:  

Mesh:

Year:  2003        PMID: 15010558

Source DB:  PubMed          Journal:  Med Wieku Rozwoj


  3 in total

1.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

2.  Human papillomavirus in women with and without HIV-1 infection attending an STI clinic in Vitoria, Brazil.

Authors:  Bettina Moulin Coelho Lima; Jonathan E Golub; Adriana Tonani Mattos; Luciana Bueno de Freitas; Liliana Cruz Spano; Angélica Espinosa Miranda
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2009-08-31

3.  Prior history of sexually transmitted diseases in women living with AIDS in São Paulo, Brazil.

Authors:  Valdir Monteiro Pinto; Mariza Vono Tancredi; Jonathan Eric Golub; Ariane de Castro Coelho; Antonio Tancredi Neto; Angelica Espinosa Miranda
Journal:  Braz J Infect Dis       Date:  2012 May-Jun       Impact factor: 1.949

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.